RT Journal Article
SR Electronic
T1 Fast SARS-CoV-2 detection protocol based on RNA precipitation and RT-qPCR in nasopharyngeal swab samples
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.26.20081307
DO 10.1101/2020.04.26.20081307
A1 ,
A1 ,
A1 Guruceaga, Xabier
A1 Sierra, Amanda
A1 Marino, Daniel
A1 Santin, Izortze
A1 Nieto-Garai, Jon Ander
A1 Bilbao, Jose Ramón
A1 Lorizate, Maier
A1 Aspichueta, Patricia
A1 Gaminde-Blasco, Adhara
A1 Bozal-Leorri, Adrian
A1 Marín-Peña, Agustín
A1 Castellanos-Rubio, Ainara
A1 Iglesias-Ara, Ainhoa
A1 Rementeria, Aitor
A1 Bernal-Chico, Ana
A1 Ramirez-Garcia, Andoni
A1 Olazagoitia-Garmendia, Ane
A1 Benito-Vicente, Asier
A1 Martín, César
A1 Castellanos, Eider Bilbao
A1 Rueda-Alaña, Eneritz
A1 Cavaliere, Fabio
A1 de Nanclares, Guiomar Perez
A1 Aurrekoetxea, Igor
A1 Garcia-Santisteban, Iraia
A1 Bernales, Irantzu
A1 Gonzalez-Moro, Itziar
A1 Tønnesen, Jan
A1 Baleriola, Jimena
A1 Vallejo-Rodríguez, Jon
A1 Aparicio-Fernandez, Leire
A1 Martin-Souto, Leire
A1 Mendoza, Luis Manuel
A1 Areitio, Maialen
A1 Sebastian-delaCruz, Maialen
A1 Ortiz-Zarragoitia, Maren
A1 Serrano-Regal, Mari Paz
A1 Basaras, Miren
A1 Fernandez-Jimenez, Nora
A1 Pampliega, Olatz
A1 Alegre, Santos Alonso
A1 Marcos, Susi
A1 Fuertes-Mendizabal, Teresa
A1 Galicia-Garcia, Unai
A1 Perez-Cuesta, Uxue
A1 Torrano, Verónica
A1 Sierra-Torre, Virginia
A1 Buqué, Xabier
A1 Mayor, Ugo
YR 2020
UL http://medrxiv.org/content/early/2020/05/01/2020.04.26.20081307.abstract
AB The SARS-CoV-2 pandemic has evolved far more aggressively in countries lacking a robust testing strategy to identify infected individuals. Given the global demand for fast and reliable diagnosis to determine the carrier individuals, a stock-out scenario for a number of essential reagents/kits used along the diagnostic process has been foreseen by many organizations. Having identified the RNA extraction step as one of the key bottlenecks, we tested several alternatives that avoid the use of commercial kits for this step. The analysis showed that 2-propanol precipitation of the viral RNA, followed by one-step RT-qPCR results in a sensitivity and specificity comparable to that provided currently by automatized systems such as the COBAS 6800 system. Therefore, this simple protocol allows SARS-CoV-2 testing independently of commercial kit providers in a time and cost-effective manner. It can be readily implemented in research and/or diagnostic laboratories worldwide, provided that patient confidentiality and researcher safety are ensured. Scaling up the testing capabilities of hospitals and research facilities will identify larger numbers of infected individuals to paint a clear picture of the COVID-19 prevalence, a pre-requisite for informed policy decision making.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis project was supported by funding from the UPV/EHU (Acción Especial “Desarrollo e implementación del test de diagnóstico para COVID-19”). None of the authors received payments or services from a third party for any aspect of the submitted work.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesRaw data will be available upon request. The protocol is open and can be found at: https://www.ehu.eus/es/web/umayor/covid-19-protocol-en